EP0955060 - REMEDIES FOR ACUTE PULMONARY INJURIES DUE TO INDIRECT CAUSES CONTAINING ANTI-IL-8 ANTIBODY AS THE ACTIVE INGREDIENT [Right-click to bookmark this link] | Status | The application has been refused Status updated on 25.11.2005 Database last updated on 24.01.2025 | Most recent event Tooltip | 25.11.2005 | Refusal of application | published on 11.01.2006 [2006/02] | Applicant(s) | For all designated states Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo 115 / JP | [N/P] |
Former [1999/45] | For all designated states Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo 115 / JP | Inventor(s) | 01 /
MATSUSHIMA, Kouji Matsudo Daisanjutaku 2-905, 159-1, Matsudo Matsudo-shi, Chiba 271 / JP | 02 /
YOKOI, Kenji 2-4-5, Nomachi Kanazawa-shi, Ishikawa 921 / JP | [1999/45] | Representative(s) | Wakerley, Helen Rachael Reddie & Grose LLP The White Chapel Building 10 Whitechapel High Street London E1 8QS / GB | [N/P] |
Former [1999/45] | Wakerley, Helen Rachael Reddie & Grose, 16 Theobalds Road London WC1X 8PL / GB | Application number, filing date | 97928485.8 | 26.06.1997 | [1999/45] | WO1997JP02221 | Priority number, date | JP19960200918 | 26.06.1996 Original published format: JP 20091896 | JP19960315378 | 22.10.1996 Original published format: JP 31537896 | [1999/45] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9749426 | Date: | 31.12.1997 | Language: | EN | [1997/57] | Type: | A1 Application with search report | No.: | EP0955060 | Date: | 10.11.1999 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.12.1997 takes the place of the publication of the European patent application. | [1999/45] | Search report(s) | International search report - published on: | JP | 31.12.1997 | (Supplementary) European search report - dispatched on: | EP | 17.06.1999 | Classification | IPC: | A61K39/395, // C07K16/24, C12P21/08 | [1999/45] | CPC: |
C07K16/24 (EP,US);
A61K39/395 (KR);
A61P11/00 (EP);
C07K16/244 (EP,US);
A61K38/00 (EP,US);
C07K2317/24 (EP,US);
C07K2319/00 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/45] | Title | German: | HEILMITTEL FÜR AKUTE AUF INDIREKTE URSACHEN ZURüCKGEHENDE LUNGENSCHÄDIGUNGEN, DIE EINEN ANTI-IL-8 ANTIKÖRPER ALS WIRKSTOFF ENTHALTEN | [1999/45] | English: | REMEDIES FOR ACUTE PULMONARY INJURIES DUE TO INDIRECT CAUSES CONTAINING ANTI-IL-8 ANTIBODY AS THE ACTIVE INGREDIENT | [1999/45] | French: | MEDICAMENTS DESTINES AUX LESIONS PULMONAIRES AIGUES DUES A DES CAUSES INDIRECTES, CONTENANT UN ANTICORPS ANTI-IL-8 COMME PRINCIPE ACTIF | [1999/45] | Entry into regional phase | 24.12.1998 | Translation filed | 11.01.1999 | National basic fee paid | 11.01.1999 | Search fee paid | 11.01.1999 | Designation fee(s) paid | 11.01.1999 | Examination fee paid | Examination procedure | 25.07.1997 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 11.01.1999 | Examination requested [1999/45] | 11.10.2002 | Despatch of a communication from the examining division (Time limit: M06) | 12.03.2003 | Reply to a communication from the examining division | 25.04.2003 | Despatch of a communication from the examining division (Time limit: M04) | 15.05.2003 | Reply to a communication from the examining division | 27.05.2003 | Despatch of a communication from the examining division (Time limit: M06) | 26.11.2003 | Reply to a communication from the examining division | 30.06.2005 | Date of oral proceedings | 26.07.2005 | Despatch of communication that the application is refused, reason: substantive examination [2006/02] | 26.07.2005 | Minutes of oral proceedings despatched | 04.08.2005 | Application refused, date of legal effect [2006/02] | Fees paid | Renewal fee | 14.06.1999 | Renewal fee patent year 03 | 13.06.2000 | Renewal fee patent year 04 | 13.06.2001 | Renewal fee patent year 05 | 12.06.2002 | Renewal fee patent year 06 | 12.06.2003 | Renewal fee patent year 07 | 14.06.2004 | Renewal fee patent year 08 | 14.06.2005 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO9523865 (GENENTECH INC [US], et al) [X] 1-6,11-21,26 * page 1, line 21 - line 33 * * page 11, line 28 - page 12, line 5 * * page 35, line 18 - page 36, line 5 *;; claims 1,5,6,26 * [Y] 8-10,23-25; | [X]WO9204372 (SCRIPPS RESEARCH INST [US]) [X] 1-6,11-21,26 * page 1, line 30 - page 2, line 34; claims 13,14 *; | [XY] - SEKIDO, NOBUAKI ET AL, "Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin - 8.", NATURE (LONDON), (1993), vol. 365, no. 6447, pages 655 - 657, XP000604920 [X] 1-7,11-22,26 * the whole document * [Y] 8-10,23-25 DOI: http://dx.doi.org/10.1038/365654a0 | [X] - MULLIGAN M S ET AL, "Inhibition of lung inflammatory reactions in rats by anti-human IL-8 antibody.", THE JOURNAL OF IMMUNOLOGY, (19930615), vol. 150, no. 12, pages 5585 - 95, XP000604925 [X] 1-6,11-21,26 * abstract * | [X] - BOYLAN A M ET AL, "Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits.", JOURNAL OF CLINICAL INVESTIGATION, (199204), vol. 89, pages 1257 - 67, XP000603440 [X] 1-6,11-21,26 * abstract * DOI: http://dx.doi.org/10.1172/JCI115710 | International search | [XP]WO9622785 (UNIV CALIFORNIA [US]); | [Y]WO9602576 (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) | [X] - J. CLIN. INVEST., 1995, Vol. 155, "Acid Aspiration-Induced Lung Injury in Rabbits is Mediated by Interleukin-8-Dependant Mechanisms", pp. 107-116. | [Y] - CYTOKINE, 1995, Vol. 7, No. 7, "Interleukin 8-Related Neutrophil Elastase and the Severity of the Adult Respiratory Distress Syndrome", pp. 746-752. | [Y] - AM. J. RESPIR. CELL. MOL. BIOL., 1992, Vol. 7, "Synthetic Surfactant (Exosurf) Inhibits Endotoxin-Stimulated Cytokine Secretion by Human Alveolar Macrophages", pp. 257-260. |